Kabra Drugs
add_icon

Kabra Drugs

18.75
+0.21
(1.13%)
Market Cap
44.50 Cr
PE Ratio
5.79
Volume
14,645.00
Day High - Low
19.40 - 18.31
52W High-Low
35.52 - 15.50
hide
Key Fundamentals
Add Ratio
split_icon_default
Market Cap
44.50 Cr
EPS
2.09
PE Ratio
5.79
PB Ratio
1.48
Book Value
12.49
EBITDA
5.80
Dividend Yield
0.00 %
Industry
Healthcare
Return on Equity
16.75
Debt to Equity
0.02
Forecast For
Actual

Company News

View All News
Caret
positive
Aanjaay Industries (formerly Kabra Drugs) reported a net profit of ₹495.98 lakh for FY26, reversing a ₹108.56 lakh loss in the prior year. Revenue surged to ₹9,274 lakh as the company resumed trading operations.
neutral
Aanjaay Industries Limited (formerly Kabra Drugs) has scheduled its 37th AGM for September 30, 2026. Key agenda items include the appointment of Ms. Moonam Kapoor as an independent director and Mrs. Twinkle Agarwal as secretarial auditor.
neutral
Kabra Drugs, now Aanjaay Industries, has appointed Twinkle Agarwal as its secretarial auditor for the financial years 2026-27 to 2027-31. The appointment was approved by the board on September 2, 2026.
View more
Competitors
LTP
Market Cap (₹ Cr.)
P/E Ratio
Revenue (₹ Cr.)
YoY Revenue Growth %
Net Profit (₹ Cr.)
YoY Profit Growth %
RSI
1,846.40
#1 4,43,013.21
36.99
#1 61,673.90
12.69
#1 11,565
26.53
41.29
9,352.00
2,48,266.22
85.61
11,067.00
13.95
2,568
65.50
61.40
4,935.00
1,87,711.54
87.65
13,886.20
20.34
2,138
3.28
51.09
1,162.30
1,16,954.58
25.23
27,657.90
17.64
5,026
-34.90
56.20
1,384.10
1,11,813.87
33.34
29,044.60
2.24
3,870
-39.18
45.24
2,006.50
1,08,322.22
100.00
6,867.80
22.01
890
#1 123.93
66.38
2,480.00
1,02,423.00
48.54
14,636.40
14.85
1,938
29.13
62.86
1,211.00
1,01,078.42
31.52
35,058.60
3.90
4,158
-69.10
61.71
1,700.00
97,814.24
26.63
34,145.20
5.56
3,503
25.21
56.69
2,135.00
97,619.15
#1 17.46
29,038.90
#1 26.75
5,356
16.00
45.93
Growth Rate
Revenue Growth
15,433.33 %
Net Income Growth
-554.55 %
Cash Flow Change
-100.85 %
ROE
-480.68 %
ROCE
-539.55 %
EBITDA Margin (Avg.)
-103.71 %

Yearly Financial Results

Annual Financials
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
TTM
Revenue
8
10
8
2
0
0
0
0
0
0
1
93
132
Expenses
8
9
7
3
0
0
0
0
0
1
2
87
123
EBITDA
0
1
1
-1
-0
0
-0
-0
-0
-1
-1
6
9
Operating Profit %
5 %
5 %
6 %
-57 %
0 %
0 %
0 %
0 %
0 %
0 %
0 %
6 %
7 %
Depreciation
0
0
0
0
0
0
0
0
0
0
0
0
0
Interest
0
0
0
0
0
0
0
0
0
0
0
0
0
Profit Before Tax
0
0
0
-2
-0
-0
-0
-0
-0
-1
-1
6
9
Tax
0
0
0
0
0
0
0
0
0
0
0
1
2
Net Profit
0
0
0
-2
-0
-0
-0
-0
-0
-1
-1
5
8
EPS in ₹
0.16
0.06
0.30
-5.37
-0.38
-0.14
-0.41
-0.42
-0.77
-1.68
-0.99
2.09
3.20

Balance Sheet

Balance Sheet
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
Total Assets
9
9
6
2
2
1
1
1
1
5
25
86
Fixed Assets
3
3
3
0
0
0
0
0
0
0
0
1
Current Assets
6
6
4
2
1
1
1
1
1
5
25
84
Capital Work in Progress
0
0
0
0
0
0
0
0
0
0
0
0
Investments
0
0
0
0
0
0
0
0
0
0
0
0
Other Assets
6
6
4
2
1
1
1
1
1
5
25
86
Total Equity & Liabilities
9
9
6
2
2
1
1
1
1
5
25
86
Current Liabilities
3
4
3
2
1
1
2
1
1
4
1
57
Non Current Liabilities
3
2
1
0
0
0
0
0
0
0
0
0
Total Equity
3
3
3
0
0
0
-0
-0
-1
1
25
30
Reserve & Surplus
-2
-2
-2
-4
-4
-4
-5
-5
-5
-6
1
6
Share Capital
4
4
4
4
4
4
4
4
4
4
24
24

Cash Flow

Cash Flow
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
Net Cash Flow
0
-0
0
0
-0
0
0
0
0
3
19
-11
Investing Activities
-0
-0
0
2
0
0
0
0
0
0
-0
-1
Operating Activities
-0
0
0
-0
-0
-0
-0
-0
-0
-0
-5
-10
Financing Activities
1
-0
-0
-1
0
0
0
0
0
3
23
0

Share Holding

% Holding
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Mar 2025
Jun 2025
Sept 2025
Dec 2025
Mar 2026
Jun 2026
Promoter
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
FIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
DIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Government
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Public / Retail
92.21 %
96.07 %
96.08 %
96.08 %
96.12 %
96.00 %
96.09 %
95.98 %
95.97 %
95.97 %
95.95 %
95.92 %
95.73 %
95.85 %
96.19 %
96.12 %
95.94 %
95.61 %
95.00 %
91.43 %
90.92 %
90.69 %
Others
7.79 %
3.93 %
3.92 %
3.92 %
3.88 %
4.00 %
3.91 %
4.02 %
4.03 %
4.03 %
4.05 %
4.08 %
4.27 %
4.15 %
3.81 %
3.88 %
4.06 %
4.39 %
5.00 %
8.57 %
9.08 %
9.31 %
No of Share Holders
7,446
7,447
7,424
7,399
7,391
7,428
7,403
7,401
7,424
7,420
7,415
7,396
7,364
7,336
7,367
7,343
7,435
7,449
8,098
8,862
9,185
9,680

Corporate Action

Record Date Corporate Action Information Announcement Day LTP at Annoucement LTP at Record Day
30 Sept 2026 ANNUAL GENERAL MEETING Annual General Meeting
NA
30 Sept 2026 19.65 18.54
02 Sept 2020 CHANGE OF NAME Change Of Name
NA
02 Sept 2020 2.80 2.80
17 Feb 2024 EXTRAORDINARY GENERAL MEETING Extraordinary General Meeting
NA
17 Feb 2024 6.22 6.85
30 Sept 2024 ANNUAL GENERAL MEETING Annual General Meeting
NA
30 Sept 2024 8.71 9.14
14 Nov 2024 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
14 Nov 2024 9.14 9.59
02 Jan 2025 EXTRAORDINARY GENERAL MEETING Extraordinary General Meeting
NA
02 Jan 2025 9.59 10.06
14 Feb 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
14 Feb 2025 10.06 10.56
30 May 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
30 May 2025 11.63 11.63
14 Aug 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
14 Aug 2025 19.80 20.19
30 Sept 2025 ANNUAL GENERAL MEETING Annual General Meeting
NA
30 Sept 2025 18.25 17.97
13 Nov 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
13 Nov 2025 19.25 20.69
26 Dec 2025 EXTRAORDINARY GENERAL MEETING Extraordinary General Meeting
NA
26 Dec 2025 29.67 29.40
13 Feb 2026 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
13 Feb 2026 29.92 33.29
29 May 2026 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
29 May 2026 25.13 25.22
12 Aug 2026 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
12 Aug 2026 24.04 23.68

Announcements

Announcement under Regulation 30 (LODR)-Newspaper PublicationSep 09, 2026
Reg. 34 (1) Annual Report.Sep 08, 2026
Submission Of Notice Of Annual General Meeting Under Regulation 30 Of The Securities And Exchange Board Of India (Listing Obligation And Disclosure Requirements) Regulations 2015Sep 07, 2026
Book Closure And Schedule Of Events For E-Voting.Sep 03, 2026
Appointment Of Internal Auditor Of The CompanySep 02, 2026
Appointment Of Secretarial Auditor Of The CompanySep 02, 2026
Board Meeting Outcome for Outcome Of Board Meeting Held On 02Nd September 2026Sep 02, 2026
Announcement under Regulation 30 (LODR)-Change in Registered Office AddressAug 29, 2026
Board Meeting Intimation for Intimation Of Board Meeting To Be Held On 02Nd September 2026Aug 27, 2026
Reconstitution Of The Composition Of The Board & Committees Of Regulation 30 Of SEBI (LODR) Regulations 2015Aug 18, 2026
Announcement under Regulation 30 (LODR)-Newspaper PublicationAug 18, 2026
Announcement under Regulation 30 (LODR)-Resignation of DirectorAug 12, 2026
Undertaking For Non- Applicability Of Regulation 32 Of SEBIAug 12, 2026
Financial Results For The Quarter Ended 30Th June 2026Aug 12, 2026
Board Meeting Outcome for Outcome Of Board Meeting Held On 12Th August 2026Aug 12, 2026
Board Meeting Intimation for Intimation Of Board Meeting To Be Held On 12-August-2026Aug 05, 2026
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jul 09, 2026
Announcement under Regulation 30 (LODR)-Change of Company NameJul 07, 2026
Closure of Trading WindowJun 26, 2026
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseJun 14, 2026
Revised Receipt Of Letter Of Intent From Chhattisgarh Government For Proposed Investment Of Rs. 200 Crore In Pharmaceutical Manufacturing Project At Nava Raipur Pharma ParkJun 13, 2026
Receipt Of Letter Of Intent From Chhattisgarh Government For Proposed Investment Of ?200 Crore In Pharmaceutical Manufacturing Project At Nava Raipur Pharma ParkJun 13, 2026
Shareholder Meeting / Postal Ballot-Scrutinizer"s ReportJun 12, 2026
Shareholder Meeting / Postal Ballot-Outcome of Postal_BallotJun 12, 2026
Announcement under Regulation 30 (LODR)-Newspaper PublicationJun 03, 2026
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseMay 30, 2026
Undertaking For Non- Applicability Of Regulation 32 Of SEBI (LODR) Regulations 2015 For The Quarter Ended On 31St March 2026.May 29, 2026
Financial Results For Quarterly & Year Ended 31St March 2026.May 29, 2026
Board Meeting Outcome for Outcome Of Board Meeting Held On 29Th May 2026May 29, 2026
Board Meeting Outcome for Outcome Of Board Meeting Held On 29Th May 2026May 29, 2026
Board Meeting Intimation for Intimation Of Board Meeting To Be Held On 29Th May 2026May 21, 2026
Compliances-Reg.24(A)-Annual Secretarial ComplianceMay 21, 2026
Announcement under Regulation 30 (LODR)-Newspaper PublicationMay 12, 2026
Shareholder Meeting / Postal Ballot-Notice of Postal BallotMay 08, 2026
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseMay 06, 2026
Board Meeting Outcome for Outcome Of Board Meeting Held On 06Th May 2026May 06, 2026
Board Meeting Intimation for Intimation Of Board Meeting To Be Held On 06Th May 2026Apr 27, 2026
Announcement under Regulation 30 (LODR)-Change in DirectorateApr 21, 2026
Board Meeting Outcome for Outcome Of Board Meeting Held On 21St April 2026Apr 21, 2026
Board Meeting Intimation for Intimation Of Board Meeting To Be Held On 21-April-2026Apr 10, 2026
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Apr 07, 2026
Closure of Trading WindowMar 25, 2026
Board Meeting Outcome for Outcome Of Board Meeting Held On 07 Th March 2026 As Per Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015.Mar 07, 2026
Board Meeting Intimation for Intimation Of Board Meeting To Be Held On March 7 2026Feb 26, 2026
Announcement under Regulation 30 (LODR)-Newspaper PublicationFeb 16, 2026
Undertaking For Non- Applicability Of Regulation 32 Of SEBI (LODR) Regulations 2015 For The Quarter Ended On 31St December 2025.Feb 13, 2026
Financial Results For The Quarter Ended 31St December 2025 Under Regulation 33 Of SEBI (Listing Obligations & Disclosure Requirements) Regulations 2015Feb 13, 2026
Board Meeting Outcome for Outcome Of Board Meeting Held On 13Th February 2026 As Per Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015.Feb 13, 2026
Board Meeting Intimation for Intimation Of Board MeetingFeb 06, 2026
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jan 06, 2026

Technical Indicators

RSI(14)
Neutral
33.06
ATR(14)
Volatile
1.51
STOCH(9,6)
Neutral
22.56
STOCH RSI(14)
Neutral
35.88
MACD(12,26)
Bearish
-0.06
ADX(14)
Weak Trend
12.61
UO(9)
Bearish
35.33
ROC(12)
Downtrend And Accelerating
-6.36
WillR(14)
Oversold
-86.43